R.H. Dinel Investment Counsel, Inc. Exact Sciences Corp Transaction History
R.H. Dinel Investment Counsel, Inc.
- $158 Million
- Q3 2024
A detailed history of R.H. Dinel Investment Counsel, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, R.H. Dinel Investment Counsel, Inc. holds 25,700 shares of EXAS stock, worth $1.27 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
25,700
Previous 25,700
-0.0%
Holding current value
$1.27 Million
Previous $1.09 Million
61.2%
% of portfolio
1.11%
Previous 0.7%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
671Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$880 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$785 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$710 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$598 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$331 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.77B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...